CINECA IRIS Institutional Research Information System

Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer

Scagliotti, Giorgio;
2002-01-01
2002
PHARMACOGENOMICS
3
6
763
780
β-tubulin III; Cisplatin resistance; CPT-11; dUTP nucleotidohydrolase; Epidermal growth factor receptor inhibitors; ERCC1; Gemcitabine resistance; Paclitaxel resistance; Pemetrexed; Plasma homocysteine; Ribonucleotide reductase; Src; STAT signaling pathways; Thymidylate synthase expression; Topoisomerase I inhibitors; TS promoter enhancer region; UGT1A1; Vinorelbine resistance; XRCC1; ZD-1839; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Pharmacogenetics; Technology, Pharmaceutical; Molecular Medicine; Genetics; Pharmacology
Sarries, Carme; Haura, Eric B.; Roig, Barbara; Taron, Miquel; Abad, Albert; Scagliotti, Giorgio; Rosell, Rafael*
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1691284
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 33
social impact